Elevated serum angiotensin converting enzyme levels as a reflection of bone marrow renin-angiotensin system activation in multiple myeloma

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 13, Issue 2, 2012, Pages 259-264

  Albayrak, Murat ^a   Celebi, Harika ^a   Albayrak, Aynur ^b   Sayilir, Abdurrahim ^c   Yesil, Yusuf ^d   Balcik, Ozlem Sahin ^e   Yokus, Osman ^f   Celik, Tugrul ^g  

^a Diskapi Education and Research Hospital   (Turkey)

^b Diskapi Education and Research Hospital   (Turkey)

^c TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

^d HACETTEPE UNIVERSITY   (Turkey)

^e FATIH UNIVERSITY   (Turkey)

^f Okmeydani Educational and Research Hospital   (Turkey)

^g Ankalab Laboratories   (Turkey)

Author keywords

Angiotensin converting enzyme; multiple myeloma; renin angiotensin system

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; ARTICLE; BONE MARROW; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; LABORATORY DIAGNOSIS; MALE; MULTIPLE MYELOMA; PATHOGENESIS; PLASMA CELL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; STATISTICAL SIGNIFICANCE;

AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; BLOOD CELL COUNT; BONE MARROW; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PEPTIDYL-DIPEPTIDASE A; RENIN-ANGIOTENSIN SYSTEM;

EID: 84861893157     PISSN: 14703203     EISSN: 17528976     Source Type: Journal    
DOI: 10.1177/1470320312437070     Document Type: Article

References (35)

1. Laubach J, Richardson P, Anderson K. Multiple myeloma. Annu Rev Med. 2011 ; 62: 249-264
2. Palumbo A, Anderson K. Multiple myeloma. N Engl J Med. 2011 ; 364: 1046-1060
3. Beyazit Y, Purnak T, Guven GS, et al. Local bone marrow renin-angiotensin system and atherosclerosis. Cardiol Res Pract. 2011 ; 2011: 714515
4. Stroth U, Unger T. The renin-angiotensin system and its receptors. J Cardiovasc Pharmacol. 1999 ; 33: S21 - S28
5. Ibiş M, Yüksel O, Yilmaz G, et al. Serum angiotensin converting enzyme levels in pancreatic diseases. Hepatogastroenterology. 2008 ; 55: 1814-1817
6. Beyazit Y, Ibis M, Purnak T, et al. Elevated levels of circulating angiotensin converting enzyme in patients with hepatoportal sclerosis. Dig Dis Sci. 2011 ; 56: 2160-2165
7. Haznedaroglu IC, Beyazit Y. Pathobiological aspects of the local bone marrow renin-angiotensin system: A review. J Renin Angiotensin Aldosterone Syst. 2010 ; 11: 205-213
8. Lubel JS, Herath CB, Burrell LM, et al. Liver disease and the renin-angiotensin system: recent discoveries and clinical implications. J Gastroenterol Hepatol. 2008 ; 23: 1327-1338
9. Leung PS, Carlsson PO. Tissue renin-angiotensin system: Its expression, localization, regulation and potential role in the pancreas. J Mol Endocrinol. 2001 ; 26: 155-164 (Pubitemid 32514606)
10. Celio MR, Inagami T. Angiotensin II immunoreactivity coexists with renin in the juxtaglomerular granular cells of the kidney. Proc Natl Acad Sci USA. 1981 ; 78: 3897-3900 (Pubitemid 11060583)
11. Thomas WG, Sernia C. The immunocytochemical localization of angiotensinogen in the rat ovary. Cell Tissue Res. 1990 ; 261: 367-373 (Pubitemid 20230575)
12. Jonsson JR, Game PA, Head RJ, et al. The expression and localisation of the angiotensin-converting enzyme mRNA in human adipose tissue. Blood Press. 1994 ; 3: 72-75 (Pubitemid 24089515)
13. Beyazit Y, Purnak T, Suvak B, et al. Increased ACE in extrahepatic cholangiocarcinoma as a clue for activated RAS in biliary neoplasms. Clin Res Hepatol Gastroenterol. 2011 ;:
14. Goker H, Haznedaroglu IC, Beyazit Y, et al. Local umbilical cord blood renin-angiotensin system. Ann Hematol. 2005 ; 84: 277-281 (Pubitemid 41166820)
15. Beyazit Y, Aksu S, Haznedaroglu IC, et al. Overexpression of the local bone marrow renin-angiotensin system in acute myeloid leukemia. J Natl Med Assoc. 2007 ; 99: 57-63 (Pubitemid 46183959)
16. Podar K, Tai YT, Lin BK, et al. Vascular endothelial growth factor-induced migration of multiple myeloma cells is associated with beta 1 integrin- and phosphatidylinositol 3-kinase-dependent PKC alpha activation. J Biol Chem. 2002 ; 277: 7875-7881 (Pubitemid 34968236)
17. Sayitoglu M, HaznedaroÄ?lu IC, Hatirnaz O, et al. Effects of imatinib mesylate on renin-angiotensin system (RAS) activity during the clinical course of chronic myeloid leukaemia. J Int Med Res. 2009 ; 37: 1018-1028
18. Li J, Volkov L, Comte L, et al. Production and consumption of the tetrapeptide AcSDKP, a negative regulator of hematopoietic stem cells, by hematopoietic microenvironmental cells. Exp Hematol. 1997 ; 25: 140-146 (Pubitemid 27101328)
19. Azizi M, Rousseau A, Ezan E, et al. Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline. J Clin Invest. 1996 ; 97: 839-844 (Pubitemid 26060543)
20. Comte L, Lorgeot V, Volkov L, et al. Effects of the angiotensin- converting enzyme inhibitor enalapril on blood haematopoietic progenitors and acetyl-N-Ser-Asp-Lys-Pro concentrations. Eur J Clin Invest. 1997 ; 27: 788-790 (Pubitemid 27414424)
21. Rodgers KE, Xiong S, Steer R, et al. Effect of angiotensin II on hematopoietic progenitor cell proliferation. Stem Cells. 2000 ; 18: 287-294 (Pubitemid 30602276)
22. Rømer FK, Emmertsen K. Serum angiotensin-converting enzyme in malignant lymphomas, leukaemia and multiple myeloma. Br J Cancer. 1980 ; 42: 314-318 (Pubitemid 10006014)
23. Buchler T, Krejci M, Svobodnik A, et al. Outcome of patients with multiple myeloma and hypertension treated with angiotensin-I-converting enzyme inhibitors during high-dose chemotherapy. Hematol J. 2005 ; 5: 559-564 (Pubitemid 40309620)
24. Paul M, Poyan Mehr A, Kreutz R. Physiology of local renin-angiotensin systems. Physiol Rev. 2006 ; 86: 747-803 (Pubitemid 44033382)
25. De Gasparo M, Catt KJ, Inagami T, et al. The angiotensin II receptors. Pharmacol Rev. 2000 ; 52: 415-472
26. Leung PS, Suen PM, Ip SP, et al. Expression and localization of AT1 receptors in hepatic Kupffer cells: Its potential role in regulating a fibrogenic response. Regul Pept. 2003 ; 116: 61-69 (Pubitemid 37352916)
27. Ager EI, Neo J, Christophi C. The renin-angiotensin system and malignancy. Carcinogenesis. 2008 ; 29: 1675-1684
28. Tamarat R, Silvestre JS, Durie M, et al. Angiotensin II angiogenic effect in vivo involves vascular endothelial growth factor- and inflammation-related pathways. Lab Invest. 2002 ; 82: 747-756 (Pubitemid 34633824)
29. Touyz RM, Schiffrin EL. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev. 2000 ; 52: 639-672
30. Escobar E, Rodríguez-Reyna TS, Arrieta O, et al. Angiotensin II, cell proliferation and angiogenesis regulator: Biologic and therapeutic implications in cancer. Curr Vasc Pharmacol. 2004 ; 2: 385-399 (Pubitemid 39200189)
31. HaznedaroÄlu IC, Tuncer S, Gürsoy M. A local renin-angiotensin system in the bone marrow. Med Hypotheses. 1996 ; 46: 507-510
32. Strawn WB, Richmond RS, Ann Tallant E, et al. Renin-angiotensin system expression in rat bone marrow haematopoietic and stromal cells. Br J Haematol. 2004 ; 126: 120-126 (Pubitemid 38859492)
33. Teresa Gomez Casares M, de la Iglesia S, Perera M, et al. Renin expression in hematological malignancies and its role in the regulation of hematopoiesis. Leuk Lymphoma. 2002 ; 43: 2377-2381 (Pubitemid 35386161)
34. Haznedaroglu IC, Oztürk MA. Towards the understanding of the local hematopoietic bone marrow renin-angiotensin system. Int J Biochem Cell Biol. 2003 ; 35: 867-880 (Pubitemid 36379328)
35. Park TS, Zambidis ET. A role for the renin-angiotensin system in hematopoiesis. Haematologica. 2009 ; 94: 745-747